iShares Genomics Immunology and Healthcare ETF | |
$ 24.2 | |
Last Holding update 2024-09-27 | 49 Stocks (0 new) |
Value $140.00 Mil | Turnover 7 % |
Portfolio Report | |
Registrant: iSHARES TRUST
|
Performance
Annualized Return %
Total Annual Return %
Key Statistics
Name | Value | ||
---|---|---|---|
Day's Open ($) | 23.98 | ||
Day's Range ($) | 23.98 - 24.2 | ||
Day's Volume | 4,580 | ||
52-Week Range ($) | 17.33 - 25.7 | ||
Beta | 1.07 | ||
Volatility | 25.85 | ||
14-Day RSI | 39.26 | ||
14-Day ATR ($) | 0.309747 | ||
20-Day SMA ($) | 24.384 |
Fundamental Data
Name | Value | ||
---|---|---|---|
Market Cap (Mil $) | 137.939 | ||
Shares Outstanding (Mil) | 5.7 | ||
PE Ratio | 27.89 | ||
PE Ratio (10y Range) | 9.5 - 30.86 | ||
PE Ratio (10y Median) | 17.7 | ||
PB Ratio | 3.46 | ||
PB Ratio (10y Range) | 2 - 5.49 | ||
PB Ratio (10y Median) | 2.9 |
Dividend Data
Name | Value | ||
---|---|---|---|
Dividends per Share (TTM) ($) | 0.281 | ||
Dividend Yield % | 1.16 | ||
Dividend Yield % (10y Range) | 0.31 - 4.03 | ||
Dividend Yield % (10y Median) | 1.05 | ||
Next Dividend Payment Date | |||
Dividend Frequency | Semi-annually |
IDNA iShares Genomics Immunology and Healthcare ETF Fundamental Charts
Historical TTM Price-to-Earnings for IDNA iShares Genomics Immunology and Healthcare ETF
Historical TTM Price-to-Earnings without NRI for IDNA iShares Genomics Immunology and Healthcare ETF
Historical Price-to-Book Ratio for IDNA iShares Genomics Immunology and Healthcare ETF
Historical Dividend Yields for IDNA iShares Genomics Immunology and Healthcare ETF
IDNA iShares Genomics Immunology and Healthcare ETF Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with ARCA:IDNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ARCA:IDNA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
iShares Genomics Immunology an... Top Holdings of 2024-07-31
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
XSWX:ROG | Roche Holding AG | 20,398 | 6604.040 | +12.88% | 4.720 | +0.54% | 0.000 | +2.30% | +19.19% | 225694.226 | Drug Manufacturers | |
GILD | Gilead Sciences Inc | 85,300 | 6487.920 | +33.53% | 4.630 | +1.16% | 0.010 | +17.56% | +13.54% | 111102.845 | Drug Manufacturers | |
SRPT | Sarepta Therapeutics Inc | 44,751 | 6365.380 | -23.82% | 4.550 | -1.35% | 0.050 | -9.94% | +37.81% | 12655.111 | Biotechnology | |
RVMD | Revolution Medicines Inc | 136,807 | 6243.870 | -32.43% | 4.460 | -1.86% | 0.080 | +3.27% | +64.05% | 7900.107 | Biotechnology | |
INCY | Incyte Corp | 93,286 | 6070.120 | +1.59% | 4.340 | +0.07% | 0.050 | -4.52% | +4.27% | 12615.171 | Biotechnology | |
REGN | Regeneron Pharmaceuticals Inc | 5,505 | 5940.940 | -9.56% | 4.240 | -0.39% | 0.000 | -12.09% | +6.52% | 103187.235 | Biotechnology | |
EXEL | Exelixis Inc | 252,226 | 5914.700 | +11.57% | 4.220 | +0.44% | 0.090 | +22.50% | +17.24% | 8024.135 | Biotechnology | |
XPAR:SAN | Sanofi SA | 56,013 | 5774.520 | +4.96% | 4.120 | +0.19% | 0.000 | +4.31% | +13.25% | 122349.479 | Drug Manufacturers | |
HKSE:06160 | BeiGene Ltd | 452,100 | 5751.950 | +31.69% | 4.110 | +0.99% | 0.030 | +33.92% | +16.53% | 184691.292 | Biotechnology | |
TSE:4502 | Takeda Pharmaceutical Co Ltd | 204,300 | 5735.570 | +16.61% | 4.100 | +0.58% | 0.010 | +1.47% | +8.58% | 6669380.769 | Drug Manufacturers |
iShares Genomics Immunology and Healthcare ETF's Historical Top Holdings Breakdowns
iShares Genomics Immunology and Healthcare ETF's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
MRNA | Moderna Inc | 2024-07-31 | Reduce | -2.15% | 115.95 ($131.89) 166.61 | $54.41 | -58.75% | Reduce -41.18% | 36,547 | -25,587 | |
RVMD | Revolution Medicines Inc | 2024-07-31 | Reduce | -1.86% | 36.92 ($40.62) 47.94 | $47.30 | 16.43% | Reduce -32.43% | 136,807 | -65,649 | |
DCPH | Deciphera Pharmaceuticals Inc | 2024-07-31 | Sold Out | -1.59% | 25.36 ($25.48) 25.59 | $25.59 | 0.43% | Sold Out | 0 | -82,525 | |
SRPT | Sarepta Therapeutics Inc | 2024-07-31 | Reduce | -1.35% | 113.33 ($137.38) 163.85 | $132.70 | -3.41% | Reduce -23.82% | 44,751 | -13,991 | |
GILD | Gilead Sciences Inc | 2024-07-31 | Add | +1.16% | 63.15 ($68.07) 78.05 | $89.24 | 31.10% | Add 33.53% | 85,300 | 21,420 | |
HKSE:06160 | BeiGene Ltd | 2024-07-31 | Add | +0.99% | 85.2 (HK$93.95) 105.4 | HK$128.30 | 36.56% | Add 31.69% | 452,100 | 108,800 | |
OCSE:GMAB | Genmab AS | 2024-07-31 | Add | +0.79% | 1719.5 (kr1885.96) 2065 | kr1,578.50 | -16.30% | Add 24.69% | 19,732 | 3,907 | |
TSE:4502 | Takeda Pharmaceutical Co Ltd | 2024-07-31 | Add | +0.58% | 4023 (円4180.61) 4312 | 円4,208.00 | 0.66% | Add 16.61% | 204,300 | 29,100 | |
MRK | Merck & Co Inc | 2024-07-31 | Reduce | -0.56% | 113.13 ($127.97) 132.96 | $104.94 | -18.00% | Reduce -11.9% | 42,237 | -5,707 | |
XSWX:ROG | Roche Holding AG | 2024-07-31 | Add | +0.54% | 214.1 (CHF245.89) 286 | CHF279.80 | 13.79% | Add 12.88% | 20,398 | 2,327 |
iShares Genomics Immunology and Healthcare ETF Total Holding History ($B)
iShares Genomics Immunology and Healthcare ETF's Asset Allocation
iShares Genomics Immunology and Healthcare ETF Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
iShares Genomics Immunology and Healthcare ETF's Hypothetical Growth since 2024-07-31
iShares Genomics Immunology and Healthcare ETF's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
iShares Genomics Immunology and Healthcare ETF's Holdings Heat Map
Size field:
iShares Genomics Immunology and Healthcare ETF's Holdings Bubble Chart
iShares Genomics Immunology and Healthcare ETF News
- 1
Discussions on iShares Genomics Immunology and Healthcare ETF
No discussions yet.